AXDX - Accelerate Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue5,6704,177246147
Cost of Revenue3,1871,002--
Gross Profit2,4833,175246147
Operating Expenses
Research Development27,63822,30129,56427,142
Selling General and Administrative55,21445,05837,18318,554
Non Recurring----
Others----
Total Operating Expenses86,03968,36166,74745,696
Operating Income or Loss-80,369-64,184-66,501-45,549
Income from Continuing Operations
Total Other Income/Expenses Net-7,74664939451
Earnings Before Interest and Taxes-80,369-64,184-66,501-45,549
Interest Expense-10,113-10,113-10,113-4
Income Before Tax-88,115-63,535-66,107-45,498
Income Tax Expense211493267-
Minority Interest----
Net Income From Continuing Ops-88,326-64,028-66,374-45,498
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-88,326-64,028-66,374-45,498
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-88,326-64,028-66,374-45,498